Cite
Duffy JP, Harrington EM, Salituro FG, et al. The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor. ACS Med Chem Lett. 2011;2(10):758-63doi: 10.1021/ml2001455.
Duffy, J. P., Harrington, E. M., Salituro, F. G., Cochran, J. E., Green, J., Gao, H., Bemis, G. W., Evindar, G., Galullo, V. P., Ford, P. J., Germann, U. A., Wilson, K. P., Bellon, S. F., Chen, G., Taslimi, P., Jones, P., Huang, C., Pazhanisamy, S., Wang, Y. M., Murcko, M. A., & Su, M. S. (2011). The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor. ACS medicinal chemistry letters, 2(10), 758-63. https://doi.org/10.1021/ml2001455
Duffy, John P, et al. "The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor." ACS medicinal chemistry letters vol. 2,10 (2011): 758-63. doi: https://doi.org/10.1021/ml2001455
Duffy JP, Harrington EM, Salituro FG, Cochran JE, Green J, Gao H, Bemis GW, Evindar G, Galullo VP, Ford PJ, Germann UA, Wilson KP, Bellon SF, Chen G, Taslimi P, Jones P, Huang C, Pazhanisamy S, Wang YM, Murcko MA, Su MS. The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor. ACS Med Chem Lett. 2011 Jul 28;2(10):758-63. doi: 10.1021/ml2001455. eCollection 2011 Oct 13. PMID: 24900264; PMCID: PMC4018046.
Copy
Download .nbib